High PD-L1 expression predicts poor prognosis in diffuse large B-cell lymphoma

被引:7
作者
Cheng, Zhiheng [1 ,2 ,3 ]
Dai, Yifeng [4 ]
Wang, Jing [1 ,2 ]
Shi, Jinlong [3 ,5 ,6 ]
Ke, Xiaoyan [1 ,2 ]
Fu, Lin [1 ,2 ]
机构
[1] Peking Univ, Hosp 3, Dept Hematol, Beijing 100191, Peoples R China
[2] Peking Univ, Hosp 3, Lymphoma Res Ctr, Beijing 100191, Peoples R China
[3] Henan Univ, Translat Med Ctr, Huaihe Hosp, Kaifeng 475000, Peoples R China
[4] Shantou Univ, Lab Environm Med & Dev Toxicol, Coll Med, Shantou 515041, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, Dept Biomed Engn, Beijing 100853, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Dept Med Big Data, Beijing 100853, Peoples R China
基金
中国国家自然科学基金;
关键词
DEATH LIGAND 1; CANCER; INHIBITION; ACTIVATION; SURVIVAL; FOXO1;
D O I
10.1007/s00277-018-3266-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1085 / 1088
页数:4
相关论文
共 13 条
[1]   PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies [J].
Chen, Benjamin J. ;
Chapuy, Bjoern ;
Jing Ouyang ;
Sun, Heather H. ;
Roemer, Margaretha G. M. ;
Xu, Mina L. ;
Yu, Hongbo ;
Fletcher, Christopher D. M. ;
Freeman, Gordon J. ;
Shipp, Margaret A. ;
Rodig, Scott J. .
CLINICAL CANCER RESEARCH, 2013, 19 (13) :3462-3473
[2]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[3]   MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma [J].
Go, Heounjeong ;
Jang, Ji-Young ;
Kim, Pil-Jong ;
Kim, Young-Goo ;
Nam, Soo Jeong ;
Paik, Jin Ho ;
Kim, Tae Min ;
Heo, Dae Seog ;
Kim, Chul-Woo ;
Jeon, Yoon Kyung .
ONCOTARGET, 2015, 6 (17) :15035-15049
[4]   Programmed cell death-1 inhibition in lymphoma [J].
Hawkes, Eliza A. ;
Grigg, Andrew ;
Chong, Geoff .
LANCET ONCOLOGY, 2015, 16 (05) :E234-E245
[5]   Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells [J].
Huang, Renxiang ;
Zhang, Dongyang ;
Li, Feng ;
Xiao, Zili ;
Wu, Meilin ;
Shi, Dongyun ;
Xiang, Ping ;
Bao, Zhijun .
ONCOLOGY LETTERS, 2017, 13 (05) :3379-3386
[6]   Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer [J].
Imawari, Yoshimi ;
Mimoto, Rei ;
Hirooka, Shinichi ;
Morikawa, Toshiaki ;
Takeyama, Hiroshi ;
Yoshida, Kiyotsugu .
CANCER SCIENCE, 2018, 109 (02) :363-372
[7]   Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma [J].
Kiyasu, Junichi ;
Miyoshi, Hiroaki ;
Hirata, Akie ;
Arakawa, Fumiko ;
Ichikawa, Ayako ;
Niino, Daisuke ;
Sugita, Yasuo ;
Yufu, Yuji ;
Choi, Ilseung ;
Abe, Yasunobu ;
Uike, Naokuni ;
Nagafuji, Koji ;
Okamura, Takashi ;
Akashi, Koichi ;
Takayanagi, Ryoichi ;
Shiratsuchi, Motoaki ;
Ohshima, Koichi .
BLOOD, 2015, 126 (19) :2193-2201
[8]   Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer [J].
Krempski, James ;
Karyampudi, Lavakumar ;
Behrens, Marshall D. ;
Erskine, Courtney L. ;
Hartmann, Lynn ;
Dong, Haidong ;
Goode, Ellen L. ;
Kalli, Kimberly R. ;
Knutson, Keith L. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (12) :6905-6913
[9]   Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma [J].
Reddy, Anupama ;
Zhang, Jenny ;
Davis, Nicholas S. ;
Moffitt, Andrea B. ;
Love, Cassandra L. ;
Waldrop, Alexander ;
Leppa, Sirpa ;
Pasanen, Annika ;
Meriranta, Leo ;
Karjalainen-Lindsberg, Marja-Liisa ;
Norgaard, Peter ;
Pedersen, Mette ;
Gang, Anne O. ;
Hogdall, Estrid ;
Heavican, Tayla B. ;
Lone, Waseem ;
Iqbal, Javeed ;
Qin, Qiu ;
Li, Guojie ;
Kim, So Young ;
Healy, Jane ;
Richards, Kristy L. ;
Fedoriw, Yuri ;
Bernal-Mizrachi, Leon ;
Koff, Jean L. ;
Staton, Ashley D. ;
Flowers, Christopher R. ;
Paltiel, Ora ;
Goldschmidt, Neta ;
Calaminici, Maria ;
Clear, Andrew ;
Gribben, John ;
Nguyen, Evelyn ;
Czader, Magdalena B. ;
Ondrejka, Sarah L. ;
Collie, Angela ;
Hsi, Eric D. ;
Tse, Eric ;
Au-Yeung, Rex K. H. ;
Kwong, Yok-Lam ;
Srivastava, Gopesh ;
Choi, William W. L. ;
Evens, Andrew M. ;
Pilichowska, Monika ;
Sengar, Manju ;
Reddy, Nishitha ;
Li, Shaoying ;
Chadburn, Amy ;
Gordon, Leo I. ;
Jaffe, Elaine S. .
CELL, 2017, 171 (02) :481-+
[10]   High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial [J].
Rossille, D. ;
Gressier, M. ;
Damotte, D. ;
Maucort-Boulch, D. ;
Pangault, C. ;
Semana, G. ;
Le Gouill, S. ;
Haioun, C. ;
Tarte, K. ;
Lamy, T. ;
Milpied, N. ;
Fest, T. .
LEUKEMIA, 2014, 28 (12) :2367-2375